Prognostic factors affecting periodontal regenerative therapy using recombinant human fibroblast growth factor-2: A 3-year cohort study.
Mikami R, Sudo T, Fukuba S, Takeda K, Matsuura T, Kariya T, Takeuchi S, Ochiai A, Kawamoto S, Toyoshima K, Mizutani K, Arakawa S, Aoki A, Iwata T.
Mikami R, et al. Among authors: aoki a.
Regen Ther. 2022 Aug 27;21:271-276. doi: 10.1016/j.reth.2022.07.006. eCollection 2022 Dec.
Regen Ther. 2022.
PMID: 36092500
Free PMC article.